9, Maryland 21204
800-725-4760 http://www.spectrumclinicalresearchinc.com/ dlowry@SpectrumClinicalResearchInc.com
Spectrum Clinical Research Inc (SCRI) is a multi-specialty clinical research trial management firm. The SCRI leadership team collectively possesses over 40 years of clinical trial management experience. This leadership team has a nationally renowned reputation for building and maintaining successful, quality research programs. Based in Central Maryland, SCRI has access to a potential volunteer pool of nearly 3 million habitants and 9 community hospitals. SCRI provides pharmaceutical, medical device and biotechnology companies with quick-study start-up, clean, quality data, and optimum patient recruitment and retention. Study participants are provided safe protocol adherence and attentive, experienced research staff. Physician investigators are supported with a streamlined research infra-structure including protocol selection, site feasibility, IRB submission, budget and contract negotiation, patient recruitment tools, and experienced, dedicated study coordinators.
The SCRI leadership team has over 40 years of cumulative inpatient and outpatient, Phase I' IV clinical trial experience in pharmaceutical and device development. The therapeutic areas include:
- Acute Coronary Syndromes
- Acute Myocardial Infarction
- Cardiac Dysrhythmias
- Cardiac Surgical Procedures
- Cardiac Anesthesiology
- Chronic Stable Angina
- Congestive Heart Failure
- Electrophysiology including Cardiac Resynchronization and Ablation
- Endocrinology
- Gene Therapy
- Gerontology
- Hyperlipidemia
- Hypertension
- Interventional Radiology
- Nuclear Imaging
- Neurology
- Pain Management
- Percutaneous Coronary Interventions (PCI)
- Peripheral Arterial Disease
- PFO closure
- Primary and Secondary Prevention
- Renal Insufficiency
- Vascular Disease (percutaneous and surgical interventions)
- Women's Health
Spectrum Clinical Research staff and associated physician investigators have managed or conducted clinical research trials with the following sponsors:
|
|
Our physician investigators possess extensive experience in clinical care AND clinical research. Our physician investigators are Board Certified in their specialty areas. The physician investigators are GCP trained and responsive to clinical research requirements and responsibilities.
Spectrum Clinical Research has a highly qualified multi-disciplinary team of dedicated health care professionals that offer extensive clinical research experience in a variety of therapeutic areas. Multi-disciplinary staff members include registered nurses, certified exercise specialists, clinical research coordinators, data entry specialists, budget & contract administrators, and regulatory affairs administrators.
Cardiology/Vascular Diseases
Endocrinology
Gastroenterology
Immunology/Infectious Diseases
Musculoskeletal
Nephrology/Urology
Neurology
Ophthalmology
Pharmacology/Toxicology
Psychiatry/Psychology
Pulmonary/Respiratory Diseases
Rheumatology
Spectrum Clinical Research Inc offers the following services and equipment at our clinical study sites:
- Access to Inpatient and Outpatient facilities
- Phlebotomy, centrifuge and laboratory processing
- Secure temperature and humidity controlled medication storage room
- Crash cart
- EKG
- Point of Care Testing
- Close proximity to public transportation
- Access to -20 and -70 degree centigrade freezers and dry ice packaging
- Exercise Stress Testing
- Holter monitoring and cardiac event monitoring
- Centralized budget, contract and IRB submission services
David R. Lowry, MPH, DrPH
President
Spectrum Clinical Research, Inc.
120 Sister Pierre Drive, Suite 304
Towson, MD 21204
USA
800-725-4760 x105 (phone)
800-625-7782 (fax)
dlowry@SpectrumClinicalResearchInc.com
www.spectrumclinicalresearchinc.com/
- A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) - TIMI 52 (SOLID)
- A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
- A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IV Trial to Evaluate the Effect of Saxagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischaemic Stroke in Patients With Type 2 Diabetes
- A Safety and Efficacy Study to Evaluate the Potential of Aleglitazar to Reduce Cardiovascular Risk in Coronary Heart Disease (CHD) Patients With a Recent Acute Coronary Syndrome (ACS) Event and Type 2 Diabetes Mellitus (T2D)
- DEFEND 2: Durable-Response Therapy Evaluation For Early- or New-Onset Type 1 Diabetes
- Double-Blind, Randomized, Single Dose Escalation Safety Study of Intraarticular Bone Morphogenic Protein (38A BMP-7) in Subjects With Osteoarthritis (OA) of the Knee
- Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment
- Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)